Effects of compounds which inhibit lymphocyte stimulation on the utilization of glucose by leukocytes.
D000227:Adenine Nucleotides / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D002247:Carbon Isotopes; D002738:Chloroquine / Q000494:pharmacology; D003078:Colchicine / Q000494:pharmacology; D003470:Culture Media; D046508:Culture Techniques; D000431:Ethanol / Q000494:pharmacology; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology; D037102:Lectins / Q000037:antagonists & inhibitors / Q000494:pharmacology; D007962:Leukocytes / Q000378:metabolism*; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D009536:Niacinamide / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology; D013997:Time Factors; D014316:Tritium
D000227:Adenine Nucleotides; D002247:Carbon Isotopes; D003470:Culture Media; D037102:Lectins; D014316:Tritium; D009536:Niacinamide; D000431:Ethanol; D010042:Ouabain; D002738:Chloroquine; D000255:Adenosine Triphosphate; D013806:Theophylline; D005947:Glucose; D003078:Colchicine; D006854:Hydrocortisone